Skip to main content
. 2020 Nov 16;11:5799. doi: 10.1038/s41467-020-19584-1

Table 1.

ERBB2 amplification status in primary and metastatic samples of a CCC patient cohort.

Amplified Not amplified Total % Amplified
Primary/local 3 302 305 1.0
Peritoneal metastasis 3 40 43 7.0

Unmatched patient tumors from primary samples (n = 305) and peritoneal metastases (tissue: n = 43) were tested by NSG to determine ERBB2 amplification validated using CISH. p Value from Fisher exact test.